Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	201	127	206	148	173.42	57.94
Short-Term Investments	888	632	803	351	555.23	130.33
Cash & Short-Term Investments	1,089	759	1,009	499	728.65	188.27
Cash Growth	36.30%	-24.78%	102.20%	-31.52%	287.02%	-26.61%
Accounts Receivable	16	38	39	745	1.05	0.13
Other Receivables	5	4	4	2	0.65	0.25
Receivables	21	42	43	747	1.7	0.38
Prepaid Expenses	17	30	15	16	5.47	4.05
Total Current Assets	1,127	831	1,067	1,262	735.82	192.71
Property, Plant & Equipment	48	143	135	137	23.59	9.33
Long-Term Investments	2	107	129	182	6.44	-
Other Long-Term Assets	75	14	14	11	6.45	1.08
Total Assets	1,252	1,095	1,345	1,592	772.29	203.11
Accounts Payable	13	17	20	10	15.68	4.7
Accrued Expenses	84	62	70	47	27.85	9.52
Current Portion of Leases	11	11	3	-	-	-
Current Income Taxes Payable	-	-	-	2	-	-
Current Unearned Revenue	105	91	97	102	74.57	7
Other Current Liabilities	2	3	3	5	3.57	1.48
Total Current Liabilities	215	184	193	166	121.67	22.71
Long-Term Leases	-	110	117	117	15.24	-
Long-Term Unearned Revenue	289	307	355	462	132.53	12.02
Other Long-Term Liabilities	115	32	23	5	0.54	4.54
Total Liabilities	687	633	688	750	269.99	39.27
Common Stock	1,602	1,311	1,206	1,118	0.01	0
Additional Paid-In Capital	-	-	-	-	830.44	369.1
Retained Earnings	-1,038	-849	-542	-275	-328.18	-205.33
Comprehensive Income & Other	1	-	-7	-1	0.04	0.06
Total Common Equity	565	462	657	842	502.3	163.84
Shareholders' Equity	565	462	657	842	502.3	163.84
Total Liabilities & Equity	1,252	1,095	1,345	1,592	772.29	203.11
Total Debt	79	121	120	117	15.24	-
Net Cash (Debt)	1,012	745	1,018	564	713.4	188.27
Net Cash Growth	22.52%	-26.82%	80.50%	-20.94%	278.93%	-26.61%
Net Cash Per Share	11.77	10.07	14.14	7.62	13.02	4.30
Filing Date Shares Outstanding	91.51	90.86	73.01	71.06	70.88	45.97
Total Common Shares Outstanding	91.5	75.5	72.9	70.78	65.11	45.93
Working Capital	912	647	874	1,096	614.15	170
Book Value Per Share	6.17	6.12	9.01	11.90	7.71	3.57
Tangible Book Value	565	462	657	842	502.3	163.84
Tangible Book Value Per Share	6.17	6.12	9.01	11.90	7.71	3.57
Machinery	-	27	20	16	11.42	9.33
Construction In Progress	-	1	4	2	2.34	0.24
Leasehold Improvements	-	54	34	32	11.11	10.83

Source: S&P Capital IQ. Standard template. Financial Sources.